|
LOC144438 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.541200E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.846000E-02 |
| Normal-vs-Stage2 |
4.432800E-01 |
| Normal-vs-Stage3 |
5.828600E-01 |
| Normal-vs-Stage4 |
3.631000E-01 |
| Stage1-vs-Stage2 |
6.865200E-01 |
| Stage1-vs-Stage3 |
5.496300E-03 |
| Stage1-vs-Stage4 |
3.823500E-03 |
| Stage2-vs-Stage3 |
2.615400E-01 |
| Stage2-vs-Stage4 |
1.740990E-01 |
| Stage3-vs-Stage4 |
6.838000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.612400E-01 |
| Normal-vs-AfricanAmerican |
7.293000E-01 |
| Normal-vs-Asian |
4.556400E-02 |
| Caucasian-vs-AfricanAmerican |
3.137200E-01 |
| Caucasian-vs-Asian |
1.913220E-01 |
| AfricanAmerican-vs-Asian |
5.633600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.564800E-01 |
| Normal-vs-Female |
1.898760E-01 |
| Male-vs-Female |
3.399000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.242800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.254380E-01 |
| Normal-vs-Age(61-80Yrs) |
6.361800E-01 |
| Normal-vs-Age(81-100Yrs) |
9.283800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.324180E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.109200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.675800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.810800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.929200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.267800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.251410E-01 |
| Normal-vs-Grade 2 |
7.196100E-03 |
| Normal-vs-Grade 3 |
6.411000E-01 |
| Normal-vs-Grade 4 |
7.237600E-02 |
| Grade 1-vs-Grade 2 |
9.217800E-01 |
| Grade 1-vs-Grade 3 |
8.267800E-02 |
| Grade 1-vs-Grade 4 |
2.919600E-02 |
| Grade 2-vs-Grade 3 |
8.49480000000291E-05 |
| Grade 2-vs-Grade 4 |
6.26579999999377E-05 |
| Grade 3-vs-Grade 4 |
7.770100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.202560E-03 |
| Normal-vs-ccB subtype |
7.410800E-01 |
| ccA subtype-vs-ccB subtype |
4.10470000000718E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.198000E-01 |
| Normal-vs-N1 |
8.097000E-01 |
| N0-vs-N1 |
4.899400E-01 |
|
|
